FTRE logo

FTRE Fortrea Holdings Inc.

NASDAQ Global Select · Biotechnology · Healthcare

$18.81
-0.05 (-0.27%)

Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services. Its Clinical Services division offers support across the entire spectrum of clinical pharmacology and development. T…

Market Cap: $1.79Bwww.fortrea.com

Price

No data yet.

Social Signal Score

50
5d
50
1 mentions
30d
50
1 mentions
60d
50
1 mentions
90d
50
1 mentions
news: 1

Revenue

$678.20M-12.94%
$502.60M$599.43M$696.27M$793.10M
Mar 2022Jun 2026

Analyst Estimates

FY2025
$0.51
$0.48$0.52
7 analysts
FY2026
$0.84+65% YoY
$0.78$0.99
7 analysts
FY2027
$1.06+27% YoY
$0.88$1.28
7 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Anshul Thakral
Sector
Healthcare
Industry
Biotechnology
Employees
14,000
Beta
1.97
Country
US
Piotroski score
5 / 9 (Middling)
Altman Z-score
0.73
www.fortrea.com